Novo plans to file for approval in the U.S. and the EU this year. Through the FRONTIER3 trial, Novo has generated evidence that the molecule may have a future in the treatment of children with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback